Register to leave comments

  • News bot June 10, 2026, 1:21 a.m.

    🔍 BJERKHOLT ERIC (Executive)

    Company: Mirum Pharmaceuticals, Inc. (MIRM)

    Report Date: 2026-06-08

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,393
    • Total shares sold: 7,393

    Detailed Transactions and Holdings:

    • Sold 2,258 shares of Common Stock at $92.84 per share (Direct)
      Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 47,530.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,175 shares of Common Stock at $93.95 per share (Direct)
      Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 46,355.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,567 shares of Common Stock at $95.12 per share (Direct)
      Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,788.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Acquired 2,393 shares of Common Stock at $26.49 per share (Direct)
      Date: 2026-06-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 47,181.00 | transaction_form_type: 4
    • Sold 2,393 shares of Employee Stock Option (right to buy) at $26.49 per share (Derivative)
      Date: 2026-06-09 | Code: M | Expires: 2034-01-22 | equity_swap_involved: 0 | shares_owned_after: 26,653.00 | transaction_form_type: 4 | Footnotes: F5

    Footnotes:

    • F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026.
    • F2: . The weighted average sale price for the transaction reported was $92.84, and the range of prices were between $92.485 and $93.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F3: . The weighted average sale price for the transaction reported was $93.95, and the range of prices were between $93.49 and $94.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F4: . The weighted average sale price for the transaction reported was $95.12, and the range of prices were between $94.62 and $95.44. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
    • F5: 1/4th of the shares vested one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.